This is the authors' abstract. We don't add key points for this paper.
We have previously shown that the univalent hapten, 2,4-dinitrophenyl (DNP)-polylysine when bound to anti-DNP-IgG antibody, yields a 7S complex which is a powerful activator of the classical pathway (Goers et al., 1975, J. Biol. Chem., 250:4918). In this paper we compare this univalent hapten-antibody complex with unassociated antibody, reduced and alkylated antibody, and IgG to which polylysine has been covalently attached. Of these, only the univalent hapten-antibody complex fixes complement. However, both antibody and reduced and alkylated antibody bind equally well to the C1q subunit of the first component, whereas only the univalent hapten-antibody complex shows enhanced binding to the intact first component, C1. Moreover, the antibody-hapten complex or hapten alone will bind to activate C1r,C1s to give C1̄r,C1̄s. The C1s, by itself, is not activated by hapten. Moreover, reassociated C1, composed of C1q,C1r,C1s, is activated by the hapten-antibody complex but not by hapten alone. These results allow us to postulate the existence of a polylysine-sensitive activation site on C1r,C1s which is concealed when C1r, C1s is associated with C1q. Furthermore, we suggest that the binding of hapten-antibody complex to C1 induces a conformational change which causes this site to become exposed. Finally, since all of the substances tested bind equally well to C1q, but only the hapten-antibody complex activates C1, we suggest that peripheral subunits on C1q serve only as anchors to bind C1 to antibody-coated cell surfaces or immune complexes and are not directly involved in the C1 activation process. Activation may occur, we speculate, when the antibody-hapten complex combines with the central stalk of C1q,C1r,C1s.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Goers et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: